GRACE C SHIH

Allopathic & Osteopathic Physicians|Ophthalmology BOSTON, MA NPI 1962846170

General Payments — all program years on this page

$2,908.58

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 44
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,309.93 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,309.9319

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Alcon Laboratories Inc $831.7812
BIOTISSUE HOLDINGS INC. $202.612
Amgen Inc. $124.921
Dompe US, Inc. $67.912
RxSight Inc $58.441
ABBVIE INC. $24.271

By program year

Program yearAmountRecords
2018 $286.025
2019 $295.835
2020 $248.252
2021 $176.354
2022 $196.284
2023 $395.925
2024 $1,309.9319

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1106087788 ABBVIE INC. $24.27 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110648184 Alcon Vision LLC $13.14 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110648186 Alcon Vision LLC $17.28 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110648188 Alcon Vision LLC $24.30 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110648190 Alcon Vision LLC $24.94 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110648192 Alcon Vision LLC $33.10 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110648194 Alcon Vision LLC $37.67 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110648196 Alcon Vision LLC $82.43 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110648198 Alcon Vision LLC $96.69 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110648200 Alcon Vision LLC $106.77 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110648202 Alcon Vision LLC $106.93 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110648204 Alcon Vision LLC $142.10 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110648206 Alcon Vision LLC $146.43 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111706372 Amgen Inc. $124.92 03/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144228168 RxSight Inc $58.44 10/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148747490 BIOTISSUE HOLDINGS INC. $76.38 04/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148774691 BIOTISSUE HOLDINGS INC. $126.23 04/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151403658 Dompe US, Inc. $33.65 06/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151403660 Dompe US, Inc. $34.26 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.